Product Code: BIO069J
Highlights:
The global market for exosome diagnostics and therapeutics should grow from $97.8 million in 2021 to $512.6 million by 2026, at compound annual growth rate (CAGR) of 39.3% for the period of 2021-2026.
The global market for bioinformatics should grow from $16.1 billion in 2020 to $24.1 billion by 2025 with a compound annual growth rate (CAGR) of 8.4% for the period of 2020-2025.
The global market for cell and gene therapy should grow from $4.1 billion in 2021 to $17.4 billion by 2026 with a compound annual growth rate (CAGR) of 33.6% for the period of 2021-2026.
Report Highlights:
- The global market for exosome diagnostics and therapeutics should grow from $97.8 million in 2021 to $512.6 million by 2026, at compound annual growth rate (CAGR) of 39.3% for the period of 2021-2026.
- The global market for bioinformatics should grow from $16.1 billion in 2020 to $24.1 billion by 2025 with a compound annual growth rate (CAGR) of 8.4% for the period of 2020-2025.
- The global market for cell and gene therapy should grow from $4.1 billion in 2021 to $17.4 billion by 2026 with a compound annual growth rate (CAGR) of 33.6% for the period of 2021-2026.
There have been a number of significant developments that has accelerated growth across the biotechnology market. These notable recent advancements include, mRNA therapeutics, CRISPR technology, biosensors and bioprinting technologies, cancer stem cell research, alongside cell and gene therapy and DNA vaccines. These advancements ensure the wide adoption of cell line technologies that support drug development and the simplification of the gene editing process, making it more cost effective long-term.
Advancement in molecular biology is supporting the delivery of molecular and computational tools and software. Synthetic biology is another field of application that promotes the manufacturing of and/or modification of genetic material in living cells.
Unlike other industries, the biotech industry has witnessed high growth throughout the pandemic. The search for diagnostic treatment methods for COVID-19 has forced governments, the media and the general public alike to focus on science and medicine, strengthening the idea that biotech acquisitions and partnerships are solid investments. Companies operating in the cell line market are now investing large amounts, enabling the development of manufacturing units with advanced, state of the art resources and expanded facilities. At the same time, genetic sequencing technology is advancing at a great pace, especially across the healthcare sector in the diagnosis of various cancers and strains of Coronavirus.
In 2019 and 2020, the biotech industry saw double digit annual growth due to fundraising from venture capitals, partnerships, co-development and joint ventures. However, the sector does continuous challenging relating to marketing, funding for innovation and pricing pressures from government organizations. Development costs are also a challenge, and often the most critical for manufacturers. While a simple cholesterol drug may cost $5 per day (approximately $1,825 per annum), a biotech drug may cost around $20,000 or more a year.
In 2019, gene therapy and cell biology technologies were successfully developed, however, this came at a high cost. For example, Zolgensma, a viral vector-based gene therapy for the treatment of spinal muscular atrophy costs around $5 million. It is important for manufacturers to figure out how to balance the cost of innovation that proves most challenging. Getting the pricing right, and the costs involved with getting the products to market are also vital challenges. Innovation may take several years to move from a clinical trial phase to market launch, and investors may face disappointment and falling stock if expectations are not managed from the offset.
This Biotechnology Research Review provides a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision making since BCC Research was founded in 1971. It includes highlights of reports published in 2021 on the following biotech markets -
- BIO149D Exosome Diagnostics and Therapeutics: Global Markets
- BIO051F Bioinformatics: Technologies and Global Markets
- BIO225A Global Cell and Gene Therapy Market
- BIO126D Next-generation Sequencing: Emerging Clinical Applications and Global Markets
- BIO083D Life Science Tools and Reagents: Global Markets
- BIO045H Global DNA Sequencing: Research, Applied and Clinical Markets
- BIO212A mRNA: Therapeutics and Global Markets
- BIO158B Cancer Stem Cells: Technologies and Global Markets
- BIO150D Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
- BIO135D Induced Pluripotent Stem Cells: Global Markets
- BIO141C Global Markets for Research Antibodies
- BIO211A Cell Therapy Biomanufacturing: Global Markets
We hope you find this Research Review valuable. We encourage you to obtain and benefit from the full market research reports that are excerpted in this Research Review. BCC Research looks forward to serving your market intelligence needs in the future.
Table of Contents
Chapter 1 Foreword
Chapter 2 Exosome Diagnostics and Therapeutics: Global Markets (BIO149D)
- Introduction
- Study Goals and Objectives
- Scope of Report
- Information Sources
- Intended Audience
- Related BCC Research Reports
- Summary and Highlights
- Market Overview
- Exosome Definition and Nomenclature
- Exosome Components
- Exosome and COVID-19 Treatment
- Exosome Diagnostic Market
- Exosome Therapeutic Market
- Market Breakdown by End User
- Market Breakdown by Region
- Patent Analysis
- U.S. Patent Analysis
- European Patent Analysis
- Pipeline Analysis
Chapter 3 Bioinformatics: Technologies and Global Markets (BIO051F)
- Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Research Methodology
- Geographic Breakdown
- Related BCC Research Reports
- Summary and Highlights
- Market Trends
- Market Breakdown
- Global Market for Bioinformatics by Sequencing Services and Platforms
- Global Market for Bioinformatics by Solution
- Global Market for Bioinformatics by End User
- Global Market for Bioinformatics by Region
- Bioinformatics Applications in Pharmaceutical R&D
- Drug Discovery and Development Process
- Clinical Research: Drug Development
- Post-Launch Ongoing Studies and Phase IV Clinical Trials
- Recent Pharmaceutical and Bioinformatics Alliances and Partnerships
- Conclusions
Chapter 4 Global Cell and Gene Therapy Market (BIO225A)
- Introduction
- Study Goals and Objectives
- Scope of This Report
- Information Sources
- Methodology
- Geographic Breakdown
- Related BCC Research Reports
- Summary and Highlights
- Highlights of the Market for Cell and Gene Therapy
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Breakdown by Product
- Market Breakdown by Application
- Market Breakdown by Region
- Pipeline Analysis
- Drugs Pending Approval
- Competitive Landscape: Overview
- Market Share Analysis
- Strategic Acquisitions and Collaborations
Chapter 5 Next-generation Sequencing: Emerging Clinical Applications and Global Markets (BIO126D)
- Introduction
- Study Goals and Objectives
- Reasons for Doing the Study
- Scope of Report
- Methodology
- Information Sources
- Geographical Breakdown
- Analyst's Credentials
- Related BCC Research Reports
- Summary and Highlights
- Next-generation Sequencing and Markets
- Clinical NGS Testing Market
- Growth Drivers of Clinical NGS
- Key Trends
- Industry
- Sequencing Technologies
- History of DNA Sequencing
- Clinical NGS Markets
- Market Dynamics
- Clinical NGS Market by Disease Category
- Clinical NGS Market by Complexity
- Clinical NGS Market by Test Purpose
- Geographical Markets
Chapter 6 Life Science Tools and Reagents: Global Markets (BIO083D)
- Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Related BCC Research Reports
- Summary and Highlights
- Market Dynamics
- Market Drivers
- Market Restraints and Challenges
- Market Opportunities
- Global Market for Life Science Tools and Reagents, by End-User Application
- Global Market for Life Science Tools and Diagnostics, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 7 Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045H)
- Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Analyst's Credentials
- Related BCC Research Reports
- Summary and Highlights
- Overview
- Sequencing Growth Driving Forces
- Research and Applied Applications
- Clinical Applications
- Market for DNA Sequencing
- Market Breakdown by Major Segment
- Geographical Markets
Chapter 8 mRNA: Therapeutics and Global Markets (BIO212A)
- Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources and Methodology
- Intended Audience
- Geographic Breakdown
- Analyst's Credentials
- Related BCC Research Reports
- Summary and Highlights
- Market Situation for RNA Therapeutics
- Well-Developed Markets
- Developing Markets
- Underdeveloped Markets
- mRNA Vaccines
- Clinical Need for mRNA Vaccines
- mRNA Vaccines and Types by Application
- Marketed/Commercial mRNA Vaccines
- mRNA Vaccines: New Developments
- mRNA Vaccines and Future Pandemics
- mRNA Drugs and Therapies
- Clinical Need for mRNA Therapeutics Beyond Vaccines
- mRNA as Gene and Protein Replacement Therapy
- mRNA-Enhanced Cell Therapies
- mRNA-Enhanced Immunotherapies (Monoclonal Antibody)
- mRNA Drugs for Protein Therapy Targeting Metabolic and Rare Diseases
- mRNA Therapeutics and New Developments
- Market Size and Growth Analysis by Product Segment
- Market Size and Growth Analysis by Therapeutic Application
- Market Size and Growth Analysis by Disease Type
- SWOT Analysis of the Market for mRNA Therapeutics
Chapter 9 Cancer Stem Cells: Technologies and Global Markets (BIO158B)
- Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources & Methodology
- Geographic Breakdown
- Analyst's Credentials
- Related BCC Research Reports
- Summary and Highlights
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Market Breakdown by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Chapter 10 Global Markets for Research Antibodies (BIO141C)
- Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Related BCC Research Reports
- Summary and Highlights
- Trends in the Market for Research Antibodies
- Purchasing Factors Analysis
- Third-Party Quality Evaluation Systems
- Research Grants
- Global Market for Research Antibodies by Product
- Global Market for Research Antibodies by Clonality
- Global Market for Research Antibodies by Major Reactivities
- Global Market for Research Antibodies by Host Species
- Global Market for Research Antibodies by End User
- Global Market for Research Antibodies by Region
- Global Company Market Ranking Analysis
Chapter 11 Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets (BIO150D)
- Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- Related BCC Research Reports
- Summary and Highlights
- Industry Overview
- Forces Driving Growth
- Key Trends
- Liquid Biopsy Initiatives
- Global Market for Liquid Biopsy by Clinical Category
- Global Market for Non-invasive Prenatal Testing
- Global Market for Liquid Biopsy for Cancer Diagnostics
- Global Market for Liquid Biopsy for Transplant Diagnostics
- Global Market for Liquid Biopsy by Purpose of Analysis
- Global Market for Liquid Biopsy by Biomarker Type
- Global Market for Liquid Biopsy by Analysis Platform
- Global Market for Liquid Biopsy by Geographic Region
Chapter 12 Induced Pluripotent Stem Cells: Global Markets (BIO135D)
- Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Related BCC Research Reports
- Summary and Highlights
- Key Drivers for Market Growth
- Technology Overview
- Induced Pluripotent Stem Cell Generation
- Induced Pluripotent Stem Cell Differentiation
- Current Challenges to iPSC Applications
- iPSCs Bank
- Impact of COVID-19 on iPSCs
- Pluripotent Stem Cells as a Study Model for COVID-19
- Scientists Use Stem Cells to Uncover COVID-19 Effects on the Heart
- Market Overview
- Market Breakdown by Region
- Market Breakdown by Reprogramming Method
- Market Breakdown by Application
- Market Breakdown by Product
- Induced Pluripotent Stem Cell-Derived Tissue Cell Market
- Induced Pluripotent Stem Cells and Their Derivative Cell Market by Species
- Market for Induced Pluripotent Stem Cells Derived Cell Market by Application
- Market for Induced Pluripotent Stem Cells by Product Function
- Research Market Compared with the Clinical Market
- Major Suppliers and Manufacturers of Induced Pluripotent Stem Cell Products
- Induced Pluripotent Stem Cell Contract Service Types
- Market Shares and Projections
Chapter 13 Cell Therapy Biomanufacturing: Global Markets (BIO211A)
- Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Related BCC Research Reports
- Summary and Highlights
- Market Breakdown by Application
- Market Breakdown by Region
- Market Trends & Challenges
- Drivers
- Restraints
- Opportunity
- Challenges